IVF Scandal: UK Families Allege Wrong Donor Sperm at Northern Cyprus Clinics

A disturbing investigation has uncovered allegations of incorrect donor sperm being used at IVF clinics in Northern Cyprus, leaving several UK families grappling with emotional and ethical consequences. The revelations, highlighted in a BBC probe, have reignited concerns over patient safety and regulation in international fertility treatments.

One of the most striking cases involves a British couple, Laura and Beth, who say they were given sperm from an unknown donor despite carefully selecting one for their IVF procedures nearly 15 years ago.

The couple had chosen a Danish donor named Finn and specifically requested that the same donor be used for both of their children to maintain a biological link. Their treatments were carried out at the Dogus IVF Center in Northern Cyprus.

However, years later, doubts began to surface when noticeable physical differences appeared after the birth of their second child. DNA testing ultimately confirmed their worst fears—the children were not genetically related to the chosen donor, nor to each other.

Multiple Families Affected

The case is not isolated. According to the BBC investigation, at least seven families who underwent IVF treatment at clinics in Northern Cyprus have reported similar concerns about incorrect sperm or egg donors being used.

Many of these families turned to commercial DNA testing, which confirmed discrepancies between the expected and actual biological origins of their children.

These findings have raised serious questions about procedural integrity and oversight at some overseas fertility clinics.

A Breach of Trust and Transparency

Laura and Beth initially chose the clinic due to its claimed association with the well-known Danish sperm bank Cryos International, which reassured them about donor screening and quality standards.

Clinic representatives had assured them that the selected donor’s sperm was properly sourced and verified. However, DNA results and subsequent investigations strongly suggest that the requested donor sperm was not used.

Attempts by the families to seek answers from clinic officials—including patient coordinator Julie Hodson and physician Firdevs Uguz Tip—were largely unsuccessful.

Dr. Firdevs reportedly questioned the validity of the DNA tests and denied involvement in ordering sperm, while also disputing her role at the clinic during the period in question—contradicting earlier information provided to patients.

Scientific Confirmation Deepens Concerns

Further DNA analysis, including tests approved for use in UK courts, confirmed that Laura and Beth’s children were conceived using different donors. The results also established that neither child was biologically related to the originally selected donor.

Forensic genetics expert Professor Denise Syndercombe Court reviewed the findings and concluded that it was highly unlikely that the children shared any biological link with the intended donor.

Other families treated by the same clinic staff have reported similar discrepancies, strengthening concerns about systemic issues rather than isolated errors.

Cryos International Responds

The CEO of Cryos International acknowledged that while human error is theoretically possible, no such incidents have been reported in the company’s 45-year History.

Fertility experts consulted during the investigation described such repeated errors as extremely rare, suggesting that negligence or deeper procedural failures could be involved.

Regulatory Gaps Raise Alarm

One of the key issues highlighted by the investigation is the lack of strict regulatory oversight in Northern Cyprus. Unlike the United Kingdom, which has robust fertility regulations, the region does not have an independent authority to monitor IVF practices.

This regulatory gap has made Northern Cyprus a popular destination for fertility treatments due to lower costs, access to anonymous donors, and services not permitted in the UK—such as non-medical gender selection.

However, experts warn that these advantages may come with significant risks, particularly when accountability mechanisms are limited.

Emotional Impact on Families

For affected families, the consequences go far beyond medical concerns. The discovery has caused emotional distress and a deep sense of betrayal.

Despite the revelations, Laura and Beth have emphasized that their love and commitment to their children remain unchanged, stressing that family bonds extend beyond genetics.

At the same time, they and others are calling for greater transparency, stricter regulations, and better safeguards to protect future patients.

Growing Calls for Accountability

The BBC investigation has intensified calls for international standards in fertility treatments and greater oversight of clinics operating in loosely regulated regions.

As more families come forward, the case is likely to fuel ongoing debates about patient safety, ethical practices, and the responsibilities of fertility providers worldwide.

For now, the incident serves as a stark reminder of the risks associated with cross-border medical treatments and the urgent need for stronger global regulation in reproductive Healthcare.